Mayinglong Pharmaceutical Group Co., LTD. (600993.SS)
CNY 26.95
(1.47%)
CNY 26.95
(1.47%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 273.47 Million CNY | -18.66% |
| 2022 | 336.2 Million CNY | 7.1% |
| 2021 | 313.92 Million CNY | 17.07% |
| 2020 | 268.15 Million CNY | -4.7% |
| 2019 | 281.39 Million CNY | 22.82% |
| 2018 | 229.11 Million CNY | 14.42% |
| 2017 | 200.23 Million CNY | -5.76% |
| 2016 | 212.47 Million CNY | -1.24% |
| 2015 | 215.13 Million CNY | -8.83% |
| 2014 | 235.97 Million CNY | 28.01% |
| 2013 | 184.34 Million CNY | 10.23% |
| 2012 | 167.24 Million CNY | -4.62% |
| 2011 | 175.33 Million CNY | 10.63% |
| 2010 | 158.49 Million CNY | 5.76% |
| 2009 | 149.86 Million CNY | 15.57% |
| 2008 | 129.67 Million CNY | 49.91% |
| 2007 | 86.5 Million CNY | 47.81% |
| 2006 | 58.51 Million CNY | 15.77% |
| 2005 | 50.54 Million CNY | 35.39% |
| 2004 | 37.33 Million CNY | 9.84% |
| 2003 | 33.99 Million CNY | 1.67% |
| 2002 | 33.43 Million CNY | 19.19% |
| 2001 | 28.04 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 316.05 Million CNY | 8.27% |
| 2024 Q2 | 291.91 Million CNY | 0.23% |
| 2024 Q1 | 291.25 Million CNY | 6.5% |
| 2023 FY | 273.47 Million CNY | -18.66% |
| 2023 Q1 | 343 Million CNY | 2.02% |
| 2023 Q4 | 273.47 Million CNY | -3.12% |
| 2023 Q2 | 343.07 Million CNY | 0.02% |
| 2023 Q3 | 282.29 Million CNY | -17.72% |
| 2022 Q1 | 275.45 Million CNY | -12.26% |
| 2022 FY | 336.2 Million CNY | 7.1% |
| 2022 Q4 | 336.2 Million CNY | -0.72% |
| 2022 Q3 | 338.64 Million CNY | 1.41% |
| 2022 Q2 | 333.94 Million CNY | 21.23% |
| 2021 Q2 | 276.8 Million CNY | -2.95% |
| 2021 Q1 | 285.22 Million CNY | 6.36% |
| 2021 FY | 313.92 Million CNY | 17.07% |
| 2021 Q3 | 296.92 Million CNY | 7.27% |
| 2021 Q4 | 313.92 Million CNY | 5.72% |
| 2020 Q1 | 320.79 Million CNY | 14.0% |
| 2020 Q3 | 332.96 Million CNY | 0.7% |
| 2020 FY | 268.15 Million CNY | -4.7% |
| 2020 Q2 | 330.64 Million CNY | 3.07% |
| 2020 Q4 | 268.15 Million CNY | -19.46% |
| 2019 Q2 | 292.32 Million CNY | 16.38% |
| 2019 FY | 281.39 Million CNY | 22.82% |
| 2019 Q4 | 281.39 Million CNY | -15.56% |
| 2019 Q3 | 333.23 Million CNY | 13.99% |
| 2019 Q1 | 251.18 Million CNY | 9.63% |
| 2018 Q2 | 222.52 Million CNY | 1.35% |
| 2018 FY | 229.11 Million CNY | 14.42% |
| 2018 Q1 | 219.56 Million CNY | 9.65% |
| 2018 Q3 | 232.2 Million CNY | 4.35% |
| 2018 Q4 | 229.11 Million CNY | -1.33% |
| 2017 FY | 200.23 Million CNY | -5.76% |
| 2017 Q2 | 198.66 Million CNY | 3.07% |
| 2017 Q3 | 232.46 Million CNY | 17.02% |
| 2017 Q4 | 200.23 Million CNY | -13.86% |
| 2017 Q1 | 192.74 Million CNY | -9.28% |
| 2016 Q2 | 237.79 Million CNY | 19.58% |
| 2016 Q3 | 222.29 Million CNY | -6.52% |
| 2016 FY | 212.47 Million CNY | -1.24% |
| 2016 Q1 | 198.86 Million CNY | -7.56% |
| 2016 Q4 | 212.47 Million CNY | -4.42% |
| 2015 Q4 | 215.13 Million CNY | -4.0% |
| 2015 FY | 215.13 Million CNY | -8.83% |
| 2015 Q2 | 233.62 Million CNY | -0.67% |
| 2015 Q1 | 235.2 Million CNY | -0.33% |
| 2015 Q3 | 224.09 Million CNY | -4.08% |
| 2014 FY | 235.97 Million CNY | 28.01% |
| 2014 Q4 | 235.97 Million CNY | 10.71% |
| 2014 Q3 | 213.14 Million CNY | 6.07% |
| 2014 Q2 | 200.94 Million CNY | 9.68% |
| 2014 Q1 | 183.2 Million CNY | -0.62% |
| 2013 Q4 | 184.34 Million CNY | -4.98% |
| 2013 Q1 | 169.13 Million CNY | 1.13% |
| 2013 Q2 | 177.85 Million CNY | 5.16% |
| 2013 Q3 | 194.01 Million CNY | 9.09% |
| 2013 FY | 184.34 Million CNY | 10.23% |
| 2012 Q2 | 191.79 Million CNY | -2.5% |
| 2012 Q1 | 196.71 Million CNY | 12.19% |
| 2012 Q3 | 184.08 Million CNY | -4.02% |
| 2012 Q4 | 167.24 Million CNY | -9.15% |
| 2012 FY | 167.24 Million CNY | -4.62% |
| 2011 Q4 | 175.33 Million CNY | -6.1% |
| 2011 Q1 | 162.21 Million CNY | 2.35% |
| 2011 Q2 | 197.81 Million CNY | 21.94% |
| 2011 FY | 175.33 Million CNY | 10.63% |
| 2011 Q3 | 186.72 Million CNY | -5.61% |
| 2010 Q3 | 180.42 Million CNY | 4.02% |
| 2010 FY | 158.49 Million CNY | 5.76% |
| 2010 Q2 | 173.44 Million CNY | -1.02% |
| 2010 Q1 | 175.24 Million CNY | 16.93% |
| 2010 Q4 | 158.49 Million CNY | -12.15% |
| 2009 Q4 | 149.86 Million CNY | -2.55% |
| 2009 FY | 149.86 Million CNY | 15.57% |
| 2009 Q3 | 153.78 Million CNY | -2.69% |
| 2009 Q2 | 158.03 Million CNY | -5.83% |
| 2009 Q1 | 167.82 Million CNY | 29.42% |
| 2008 Q4 | 129.67 Million CNY | -12.11% |
| 2008 Q2 | 88.27 Million CNY | 9.2% |
| 2008 Q1 | 80.83 Million CNY | -6.55% |
| 2008 Q3 | 147.54 Million CNY | 67.15% |
| 2008 FY | 129.67 Million CNY | 49.91% |
| 2007 Q3 | 79.39 Million CNY | 17.23% |
| 2007 Q2 | 67.72 Million CNY | 9.84% |
| 2007 FY | 86.5 Million CNY | 47.81% |
| 2007 Q1 | 61.65 Million CNY | 5.36% |
| 2007 Q4 | 86.5 Million CNY | 8.95% |
| 2006 Q3 | 70.33 Million CNY | -1.23% |
| 2006 Q4 | 58.51 Million CNY | -16.8% |
| 2006 FY | 58.51 Million CNY | 15.77% |
| 2006 Q2 | 71.21 Million CNY | -1.95% |
| 2006 Q1 | 72.62 Million CNY | 43.68% |
| 2005 Q1 | 48.84 Million CNY | 30.83% |
| 2005 Q3 | 52.01 Million CNY | 3.13% |
| 2005 FY | 50.54 Million CNY | 35.39% |
| 2005 Q2 | 50.43 Million CNY | 3.26% |
| 2005 Q4 | 50.54 Million CNY | -2.82% |
| 2004 FY | 37.33 Million CNY | 9.84% |
| 2004 Q3 | 39.44 Million CNY | 10.41% |
| 2004 Q2 | 35.72 Million CNY | 0.0% |
| 2004 Q4 | 37.33 Million CNY | -5.36% |
| 2003 Q4 | 33.99 Million CNY | 0.0% |
| 2003 FY | 33.99 Million CNY | 1.67% |
| 2002 FY | 33.43 Million CNY | 19.19% |
| 2001 FY | 28.04 Million CNY | 0.0% |